|
|
Line 170: |
Line 170: |
| <td><h2>2. Best New Composite Part<span class="head">: <a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a></span></h2></td> | | <td><h2>2. Best New Composite Part<span class="head">: <a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a></span></h2></td> |
| </tr> | | </tr> |
- | <tr>
| + | <td><p class="head">•Prhl(RL)-CmR-LasI (<a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>)</p></td> |
- | <td><p class="head">• Plux-CmR-RhlI (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>)</p></td>
| + | |
| </tr> | | </tr> |
| + | |
| + | <tr> |
| + | |
| <tr> | | <tr> |
- | <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0070">BBa_C0070</a>. (CmR is Chloramphenicol resistance.)</p> | + | <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a> <a href="http://parts.igem.org/Part:BBa_K395160">BBa_K395160</a> <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>and<a href="http://parts.igem.org/Part:BBa_C0078">BBa_C0078</a>Prhl(RL) promoter has no leakage and higher expression than Prhl promoter (BBa_R0071). CmR and LasI are inserted into the downstream of the promoter</p> |
- | <p class="info-18"This is the first BioBrick part that succeeded in 3OC12HSL dependent CmR and C4HSL production. In our experiment, we used 3OC12HSL instead of 3OC6HSL as an inducer in order to circumvent crosstalk. Using this part with the plasmid that is constitutively expressing LuxR, we succeeded in confirming LuxR activates the expression of CmR and RhlI in the presence of 3OC12HSL. </p> | + | <p class="info-18"This is the first BioBrick part that succeeded in C4HSL dependent CmR and 3OC12HSL production. Using this part with the plasmid that is constitutively expressing RhlR, we succeeded in confirming RhlR activates the expression of CmR and LasI in the presence of C4HSL. </p> |
- | <p class="info-18">To confirm C4HSL production, we measured the expression of GFP in reporter cells by flow cytometer. (Fig. 5-1-2-1).</p> | + | <p class="info-18"> |
| + | To confirm CmR production, we added chloramphenicol into the medium containing Prhl(RL)-CmR-LasI cell and measured optical density for about 8 h to estimate the concentration of the cell. (Fig. 5-1-2-1.) |
| + | </p> |
| <p class="info-18"> Moreover, by co-culturing the cells containing this part with the cells containing 3OC12HSL dependent C4HSL producer part (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>), we succeeded in constructing a positive feedback system. </p></td> | | <p class="info-18"> Moreover, by co-culturing the cells containing this part with the cells containing 3OC12HSL dependent C4HSL producer part (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>), we succeeded in constructing a positive feedback system. </p></td> |
| </tr> | | </tr> |
Line 189: |
Line 193: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="head">•Prhl(RL)-CmR-LasI (<a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>)</p></td> | + | |
| + | |
| + | <tr> |
| + | <td><p class="head">• Plux-CmR-RhlI (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>)</p></td> |
| </tr> | | </tr> |
- | <tr>
| + | <tr> |
| <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0070">BBa_C0070</a>. (CmR is Chloramphenicol resistance.) <br /> | | <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0070">BBa_C0070</a>. (CmR is Chloramphenicol resistance.) <br /> |
| This is the first BioBrick part that succeeded in 3OC12HSL dependent CmR and C4HSL production. In our experiment, we used 3OC12HSL instead of 3OC6HSL as an inducer in order to circumvent crosstalk. Using this part with the plasmid that is constitutively expressing LuxR, we succeeded in confirming LuxR activates the expression of CmR and RhlI in the presence of 3OC12HSL. </p> | | This is the first BioBrick part that succeeded in 3OC12HSL dependent CmR and C4HSL production. In our experiment, we used 3OC12HSL instead of 3OC6HSL as an inducer in order to circumvent crosstalk. Using this part with the plasmid that is constitutively expressing LuxR, we succeeded in confirming LuxR activates the expression of CmR and RhlI in the presence of 3OC12HSL. </p> |
Line 207: |
Line 214: |
| <td> </td> | | <td> </td> |
| </tr> | | </tr> |
- | <tr>
| |
| <td><h2>3. Best Part Collection: <span class="head"><a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a><a href="http://parts.igem.org/Part:BBa_K1139201" rel="nofollow"></a></span> </h2></td> | | <td><h2>3. Best Part Collection: <span class="head"><a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a><a href="http://parts.igem.org/Part:BBa_K1139201" rel="nofollow"></a></span> </h2></td> |
| </tr> | | </tr> |